A Vanillylidenehydrazide, Isonicotinic Acid CEP of the European Pharmacopoeia monograph is often referred to as a Vanillylidenehydrazide, Isonicotinic Acid Certificate of Suitability (COS). The purpose of a Vanillylidenehydrazide, Isonicotinic Acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vanillylidenehydrazide, Isonicotinic Acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vanillylidenehydrazide, Isonicotinic Acid to their clients by showing that a Vanillylidenehydrazide, Isonicotinic Acid CEP has been issued for it. The manufacturer submits a Vanillylidenehydrazide, Isonicotinic Acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vanillylidenehydrazide, Isonicotinic Acid CEP holder for the record. Additionally, the data presented in the Vanillylidenehydrazide, Isonicotinic Acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vanillylidenehydrazide, Isonicotinic Acid DMF.
A Vanillylidenehydrazide, Isonicotinic Acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vanillylidenehydrazide, Isonicotinic Acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vanillylidenehydrazide, Isonicotinic Acid suppliers with CEP (COS) on PharmaCompass.